about
Anopheles gambiae odorant binding protein crystal complex with the synthetic repellent DEET: implications for structure-based design of novel mosquito repellentsCrystal structures of Trypanosoma brucei oligopeptidase B broaden the paradigm of catalytic regulation in prolyl oligopeptidase family enzymesTracing binding modes in hit-to-lead optimization: chameleon-like poses of aspartic protease inhibitorsDiamond: shedding light on structure-based drug discoveryBiochemical and structural characterization of an essential acyl coenzyme A carboxylase from Mycobacterium tuberculosiseMatchSite: sequence order-independent structure alignments of ligand binding pockets in protein modelsKB-Rank: efficient protein structure and functional annotation identification via text queryCorrelating Calmodulin Landscapes with Chemical Catalysis in Neuronal Nitric Oxide Synthase using Time-Resolved FRET and a 5-Deazaflavin Thermodynamic TrapHerbacetin Is a Novel Allosteric Inhibitor of Ornithine Decarboxylase with Antitumor Activity.HAAD: A quick algorithm for accurate prediction of hydrogen atoms in protein structures.Computational methods in drug discovery.Probing the structure of Leishmania major DHFR TS and structure based virtual screening of peptide library for the identification of anti-leishmanial leads.Docking to RNA via root-mean-square-deviation-driven energy minimization with flexible ligands and flexible targets.What is next for small-molecule drug discovery?New disturbing trend in antimicrobial resistance of gram-negative pathogensIn vivo crystallography at X-ray free-electron lasers: the next generation of structural biology?EDULISS: a small-molecule database with data-mining and pharmacophore searching capabilitiesPostgenomic strategies in antibacterial drug discovery.Virtual screening for potential inhibitors of Mcl-1 conformations sampled by normal modes, molecular dynamics, and nuclear magnetic resonance.Target assessment for antiparasitic drug discovery.Current challenges and trends in the discovery of agrochemicals.2.8 Å resolution reconstruction of the Thermoplasma acidophilum 20S proteasome using cryo-electron microscopy.Binding modes of peptidomimetics designed to inhibit STAT3.Blocking protein kinase C signaling pathway: mechanistic insights into the anti-leishmanial activity of prospective herbal drugs from Withania somnifera.Neuropsychiatric Effects of HIV Antiviral Medications.The current state of drug discovery and a potential role for NMR metabolomics.DINC: a new AutoDock-based protocol for docking large ligands.Discovery of Akt kinase inhibitors through structure-based virtual screening and their evaluation as potential anticancer agents.Challenges, applications, and recent advances of protein-ligand docking in structure-based drug design.Chemical approaches to the discovery and development of cancer therapies.NMR-Assisted Molecular Docking Methodologies.Discovery of novel 1,2,3-triazole derivatives as anticancer agents using QSAR and in silico structural modificationBiofocussed chemoprospecting: An efficient approach for drug discovery.Crystal structure and stability of gyrase-fluoroquinolone cleaved complexes from Mycobacterium tuberculosis.A polyalanine peptide derived from polar fish with anti-infectious activitiesInnovative lead discovery strategies for tropical diseases.Molecular drug targets and structure based drug design: A holistic approach.Carbonic anhydrase as a model for biophysical and physical-organic studies of proteins and protein-ligand binding.Structure-Based Design of Anticancer Prodrug PABA/NO.From local structure to a global framework: recognition of protein folds.
P2860
Q27670428-73CB3E3D-D1F4-4B26-B62D-4C7DF1145EBEQ27680672-083367EC-44E3-48B6-B5B9-48E5CD797F80Q27697678-9E1E5183-B9E1-4014-A4B7-DBC8B46935BBQ28082915-D59293F9-17D2-4753-BFFA-12246BB5F672Q28486901-DA3713A7-DBCD-4210-9EA9-0DD783B72BD4Q28543048-BC785674-2D2C-4124-A552-AE135E026DEEQ28728482-43FA7F5F-7246-4367-B917-FA0989DD120CQ28829445-EDFA0CD9-D97F-42A9-9256-D0142065D015Q30362087-55056781-510D-4197-9F47-C3545D93534DQ30379961-AB2368DD-CC7B-48BA-AFFA-7C3A79C87034Q30398071-67717752-0748-4B61-BDB3-D64CC84254D7Q30415908-DBCE8969-3BB6-439D-B1BD-8258194F005EQ30495708-87B734DE-3BBE-479D-80B4-825A81271E69Q31004268-038C3EDE-E26A-4579-80AF-B2C500474F2EQ33422956-6F223811-276F-40B9-82CA-26A1DA9A9771Q33738426-4A6A6736-7DE9-4A24-9785-03D69F4A03B5Q33738554-A0FF1886-FA15-4257-A48C-2D68690CCA53Q33745572-58BDB857-2DCE-4511-8C69-7727A617EA63Q33834795-A2C59EF6-2109-4B1C-80FF-861C2C44F984Q34301994-12BE0B4B-49E7-405A-8C18-D0096911ABEEQ34364424-BBCC40A5-77CD-410D-9561-00D59DDBDFE9Q34466607-0220C97B-FFB5-411C-B2EB-1D119DA59509Q34516992-118C7E58-E824-45C6-BDF7-70F7202E905DQ34529900-00A478F3-881A-47B4-9E51-2EE369484902Q34537705-049D6CBC-5BAD-426B-8D41-125787C535E1Q35072850-7281E3C6-72C7-4800-86F3-E70B621F9596Q35101950-D58BB10C-E9E4-45E7-AB99-040F37F00E87Q35139006-036A65F9-5B20-4900-A5E4-A90AA2E2C367Q35206344-31F242D2-B6A3-4890-81BD-E240AA815448Q36085630-35B90F9D-CF4B-45BE-A0D6-725F8F07B5E0Q36094967-B468E69F-8D5A-4C17-8FA9-E4000E61BD2BQ36234222-9F27FBFD-8324-443D-81AF-A6806133E2D7Q36264598-6BD64A10-BF46-4CCF-9A44-331D325DFCD2Q36607637-B48F9FF0-9B82-42C7-AB12-A1B39E2FA7EBQ36621683-F3941CC4-46F4-4C81-AC0C-C1DD6B472E43Q36642049-F72241B0-F148-4BFA-B8B0-2399DBA05933Q36863549-D6570EC3-402B-43EA-9B2B-8089AC93B3D1Q37108161-8C28F5C8-96CB-42FF-9994-3978FE7858C7Q37290424-32B0D174-8B38-4A39-A8AA-5A739479627EQ37735364-C271BE27-6339-45C3-AA31-16CF43C963B9
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
The process of structure-based drug design.
@ast
The process of structure-based drug design.
@en
The process of structure-based drug design.
@nl
type
label
The process of structure-based drug design.
@ast
The process of structure-based drug design.
@en
The process of structure-based drug design.
@nl
prefLabel
The process of structure-based drug design.
@ast
The process of structure-based drug design.
@en
The process of structure-based drug design.
@nl
P1476
The process of structure-based drug design.
@en
P2093
Amy C Anderson
P304
P356
10.1016/J.CHEMBIOL.2003.09.002
P577
2003-09-01T00:00:00Z